Home › Parkinson's Disease › Ohio › Columbus
Parkinson's Disease clinical trials in Columbus, OH
6 studies for Parkinson's Disease are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RecruitingPhase 2
- The Ohio State University, Columbus
A Study of Buntanetap in Participants With PD
RecruitingPhase 2/3
- The Ohio State University Wexner Medical Center, Columbus
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
RecruitingObservational study
- Ohio State University, Columbus
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RecruitingPhase 2
- The Ohio State University Wexner Medical Center (site #207), Columbus
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
RecruitingObservational study
- Ohio State Medical, Columbus
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
RecruitingObservational study
- The Ohio State University, Columbus
About Parkinson's Disease
Parkinson's disease (PD) is a movement disorder. It causes tremors, stiffness, and slow movement. It gets worse over time. Learn what can help.
More about Parkinson's Disease on MedlinePlus
Parkinson's Disease trials in other cities
- New York City, NY23 studies
- Boston, MA19 studies
- Cleveland, OH18 studies
- Minneapolis, MN17 studies
- Nashville, TN15 studies
- Philadelphia, PA14 studies
- San Francisco, CA14 studies
- New Haven, CT14 studies
- Farmington Hills, MI13 studies
- Charleston, SC13 studies
- Chicago, IL13 studies
- Miami, FL13 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer56 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Colorectal Cancer24 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.